Treatment of Hodgkin's disease.
D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006689:Hodgkin Disease / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D007813:Laparotomy; D008297:Male; D008722:Methods; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D010166:Palliative Care; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D011882:Radiotherapy, High-Energy; D012075:Remission, Spontaneous; D014750:Vincristine / Q000627:therapeutic use
D009588:Nitrogen Mustard Compounds; D011344:Procarbazine; D014750:Vincristine; D011241:Prednisone